Primary and secondary prevention of cervical cancer.

Abstract:

:The burden of cervical cancer is very high in low-resource countries, while it is lower in several high-income countries. Secondary prevention based on cervical screening has been very successful in countries where the resources exist to ensure high-quality and good coverage of the population at risk. In many developed countries that have effective organized screening programs, cervical cancer incidence and mortality rates have been reduced substantially. However, the cervical screening is generally inefficient and unworkable in the many regions of the world where the appropriate infrastructure is missing. Primary prevention by prophylactic vaccination against the major cause of cervical cancer, the carcinogenic human papillomavirus types 16 and 18, is now available worldwide and offers additional protection from cervical cancer. This review focuses on basic knowledge about cervical cancer and challenges in the new era of cervical cancer prevention.

journal_name

Expert Rev Mol Diagn

authors

Grce M

doi

10.1586/erm.09.64

subject

Has Abstract

pub_date

2009-11-01 00:00:00

pages

851-7

issue

8

eissn

1473-7159

issn

1744-8352

journal_volume

9

pub_type

杂志文章,评审
  • The HER2 CISH pharmDx(™) Kit in the assessment of breast cancer patients for anti-HER2 treatment.

    abstract::Testing for amplification of the human EGF receptor 2 (HER2) gene by in situ hybridization is a central principle for the identification of breast cancer patients likely to respond to treatments directed toward HER2. However, its application in clinical routine has been somewhat restricted by the typical use of a visu...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章

    doi:10.1586/erm.13.6

    authors: Foged NT,Brügmann A,Jørgensen JT

    更新日期:2013-04-01 00:00:00

  • Liquid biopsy in the clinical management of bladder cancer: current status and future developments.

    abstract::Introduction: The use of liquid biopsy on the blood from solid malignancies provides a convenient way of detecting actionable mutations, monitoring treatment response, detecting early recurrence and prognosticating outcomes. The aim of this review is to discuss the current status and future direction of serum biomarke...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章

    doi:10.1080/14737159.2019.1680284

    authors: Kouba E,Lopez-Beltran A,Montironi R,Massari F,Huang K,Santoni M,Chovanec M,Cheng M,Scarpelli M,Zhang J,Cimadamore A,Cheng L

    更新日期:2020-02-01 00:00:00

  • Pharmacogenetics: the Rx perspective.

    abstract::Pharmacogenetics is changing the way medicines are discovered, developed and delivered to patients. In this article, we present the 'prescription' perspective--how the results of pharmacogenetic research will help minimize the risk of costly adverse drug reactions and treatment failures, by providing predictive tools ...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章

    doi:10.1586/14737159.1.3.255

    authors: Renegar G,Rieser P,Manasco P

    更新日期:2001-09-01 00:00:00

  • Single-tube methylation-specific duplex-PCR assay for rapid and accurate diagnosis of Fragile X Mental Retardation 1-related disorders.

    abstract:AIM:Molecular diagnosis of fragile X syndrome demands assessment of fragile X mental retardation 1 (FMR1) CGG repeat size and methylation status, while predicting disease transmission risk requires determination of AGG interruption pattern. There is currently no single assay that provides all three categories of inform...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章

    doi:10.1586/14737159.2015.1001749

    authors: Rajan-Babu IS,Teo CR,Lian M,Lee CG,Law HY,Chong SS

    更新日期:2015-03-01 00:00:00

  • Non-coding RNAs as clinical biomarkers for cancer diagnosis and prognosis.

    abstract::Developing more precise diagnostics approaches to predict cancer progression and prognosis is the key to precision medicine. Overwhelming evidence now suggests that small non-coding RNAs such as miRNAs can be useful tools as biomarkers for molecular diagnostics. miRNAs can serve as biomarkers in a variety of diseases,...

    journal_title:Expert review of molecular diagnostics

    pub_type: 社论

    doi:10.1586/14737159.2014.971761

    authors: Mishra PJ

    更新日期:2014-11-01 00:00:00

  • Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target.

    abstract::Lipoprotein-associated phospholipase (Lp-PL)A2 is a recently described and potentially useful plasma biomarker associated with cardiovascular disease. The enzyme, originally named platelet-activating factor acetylhydrolase (PAF-AH), has two prominent biological activities. First, it inactivates the prominent proinflam...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.7.5.511

    authors: Carlquist JF,Muhlestein JB,Anderson JL

    更新日期:2007-09-01 00:00:00

  • Prognostic and predictive biomarkers in prostate cancer.

    abstract::Prostate cancer (PCa) is one of the leading causes of cancer death among males, especially in more developed countries. Diagnosis is often achieved at an early stage of the disease with prostate biopsy, following a screening test showing elevated serum levels of prostate-specific antigen or a positive digital rectal e...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.2015.1110022

    authors: Kontos CK,Adamopoulos PG,Scorilas A

    更新日期:2015-01-01 00:00:00

  • Novel fluorescent microarray platforms: a case study in neurodegenerative disorders.

    abstract::This review focuses on the fluorescent protein microarrays applied to neurodegenerative disorders, a major health problem in our aging society. Biomarker discovery studies and work on new diagnostic tests are both included. Three platforms are described: antibody planar microarrays, comprising an array of well-defined...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.2013.849574

    authors: Cretich M,Sola L,Gagni P,Chiari M

    更新日期:2013-11-01 00:00:00

  • Paper-based analytical devices for clinical diagnosis: recent advances in the fabrication techniques and sensing mechanisms.

    abstract:INTRODUCTION:There is a significant interest in developing inexpensive portable biosensing platforms for various applications including disease diagnostics, environmental monitoring, food safety, and water testing at the point-of-care (POC) settings. Current diagnostic assays available in the developed world require so...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1080/14737159.2017.1285228

    authors: Sher M,Zhuang R,Demirci U,Asghar W

    更新日期:2017-04-01 00:00:00

  • Diagnostic potential of peritoneal fluid biomarkers of endometriosis.

    abstract::Endometriosis is defined as the presence of endometrial glands and stroma outside the uterus, in different parts of the peritoneal cavity. It affects up to 10% of reproductive-age women and up to 50% of women with infertility. Surgical diagnosis of endometriosis is still the gold standard, with no diagnostic biomarker...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.2015.1015994

    authors: Rižner TL

    更新日期:2015-04-01 00:00:00

  • DNA methylation and cancer diagnosis: new methods and applications.

    abstract::Methylation of cytosines in cytosine-guanine (CpG) dinucleotides is one of the most important epigenetic alterations in animals. The presence of methylcytosine in the promoter of specific genes has profound consequences on local chromatin structure and on the regulation of gene expression. Changes in DNA methylation p...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/erm.09.53

    authors: Dehan P,Kustermans G,Guenin S,Horion J,Boniver J,Delvenne P

    更新日期:2009-10-01 00:00:00

  • Bioinformatic approaches for modeling the substrate specificity of HIV-1 protease: an overview.

    abstract::HIV-1 protease has a broad and complex substrate specificity, which hitherto has escaped a simple comprehensive definition. This, and the relatively high mutation rate of the retroviral protease, makes it challenging to design effective protease inhibitors. Several attempts have been made during the last two decades t...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.7.4.435

    authors: Rögnvaldsson T,You L,Garwicz D

    更新日期:2007-07-01 00:00:00

  • Rapid aneuploidy screening (FISH or QF-PCR): the changing scene in prenatal diagnosis?

    abstract::The accuracy of new molecular diagnostics, fluoresence in situ hybridization or quantitative fluorescence-PCR (collectively known as rapid aneuploidy screening), in prenatal diagnosis has already been demonstrated in a number of large studies. The challenge now is how to apply them clinically in the most cost-effectiv...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.4.3.333

    authors: Leung WC,Lau ET,Lao TT,Tang MH

    更新日期:2004-05-01 00:00:00

  • Advances in clinical next-generation sequencing: target enrichment and sequencing technologies.

    abstract::The huge parallel sequencing capabilities of next generation sequencing technologies have made them the tools of choice to characterize genomic aberrations for research and diagnostic purposes. For clinical applications, screening the whole genome or exome is challenging owing to the large genomic area to be sequenced...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.2016.1133298

    authors: Ballester LY,Luthra R,Kanagal-Shamanna R,Singh RR

    更新日期:2016-01-01 00:00:00

  • Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.

    abstract::In the field of oncology, clinical molecular diagnostics and biomarker discoveries are constantly advancing as the intricate molecular mechanisms that transform a normal cell into an aberrant state in concert with the dysregulation of alternative complementary pathways are increasingly understood. Progress in biomarke...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/erm.12.59

    authors: Ong FS,Das K,Wang J,Vakil H,Kuo JZ,Blackwell WL,Lim SW,Goodarzi MO,Bernstein KE,Rotter JI,Grody WW

    更新日期:2012-07-01 00:00:00

  • Information management driven by diagnostic patient data: right information for the right patient.

    abstract::Existing and future diagnostic technologies are providing a huge amount of data about the patient, which are to be sensibly managed by the treating physician. More than that, the sheer complexity of the interrelation between these data are calling for a radically new approach in the handling of medical data and inform...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.2.4.355

    authors: Fierz W

    更新日期:2002-07-01 00:00:00

  • Epigenetic alteration of microRNAs in feces of colorectal cancer and its clinical significance.

    abstract::MicroRNAs regulate target gene expression through translation repression or mRNA decay, and they are emerging as important modulators in cellular pathways. Previous studies have shown the occurrence of epigenetically modified miRNAs in colorectal cancer (CRC), identifying these miRNA methylation signatures may provide...

    journal_title:Expert review of molecular diagnostics

    pub_type: 评论,杂志文章

    doi:10.1586/erm.11.57

    authors: Cho WC

    更新日期:2011-09-01 00:00:00

  • Nanodiagnostics for tuberculosis detection.

    abstract:INTRODUCTION:Tuberculosis (TB) is a leading killer worldwide. End TB strategy aims at ending the TB epidemic by 2030. Early, accurate, and affordable diagnosis represents a cornerstone to achieve this goal. Innovative strategies for TB diagnostics have been introduced. However, the ideal assay is yet unavailable and co...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1080/14737159.2017.1308825

    authors: El-Samadony H,Althani A,Tageldin MA,Azzazy HME

    更新日期:2017-05-01 00:00:00

  • Molecular markers related to immunosurveillance as predictive and monitoring tools in non-small cell lung cancer: recent accomplishments and future promises.

    abstract::Introduction: The landscape of systemic treatment options for lung cancer has rapidly evolved with the emergence of immunomodulatory agents such as neutralizing antibodies targeting the programmed cell death protein 1 (PD-1) and its ligand (PD-L1). Another major breakthrough was the introduction of biomarkers, such as...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章

    doi:10.1080/14737159.2020.1724785

    authors: Michaelidou K,Agelaki S,Mavridis K

    更新日期:2020-03-01 00:00:00

  • Dominant spinocerebellar ataxias: a molecular approach to classification, diagnosis, pathogenesis and the future.

    abstract::The capacity to use molecular techniques to establish the genetic diagnoses of the autosomal dominant ataxias has revolutionized the field. It is now possible to systematically classify these disorders according to the nature of the causative mutation, with implications for diagnostic testing, analysis of pathogenesis...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.3.6.715

    authors: Margolis RL

    更新日期:2003-11-01 00:00:00

  • Novel technologies emerging for preimplantation genetic diagnosis and preimplantation genetic testing for aneuploidy.

    abstract:INTRODUCTION:Preimplantation genetic diagnosis (PGD) was introduced as an alternative to prenatal diagnosis: embryos cultured in vitro were analysed for a monogenic disease and only disease-free embryos were transferred to the mother, to avoid the termination of pregnancy with an affected foetus. It soon transpired tha...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1080/14737159.2017.1262261

    authors: Sermon K

    更新日期:2017-01-01 00:00:00

  • Progress and prospects of next-generation sequencing testing for inherited retinal dystrophy.

    abstract::Next-generation sequencing, also known as massively paralleled sequencing, offers an unprecedented opportunity to study disease mechanisms of inherited retinal dystrophies: a dramatic change from a few years ago. The specific involvement of the retina and the manageable number of genes to sequence make inherited retin...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.2015.1081057

    authors: Chiang JP,Lamey T,McLaren T,Thompson JA,Montgomery H,De Roach J

    更新日期:2015-01-01 00:00:00

  • PNA FISH: present and future impact on patient management.

    abstract::Inappropriate and inaccurate antimicrobial therapy can lead to adverse patient outcomes and also the development of antimicrobial resistance. Peptide nucleic acid (PNA) fluorescence in situ hybridization (FISH) gives rapid reporting with highly sensitive and specific results to clinicians within 3 h after blood cultur...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.7.3.231

    authors: Forrest GN

    更新日期:2007-05-01 00:00:00

  • Next-generation sequencing in precision oncology: challenges and opportunities.

    abstract::High throughput gene sequencing is transforming the utilization of genomics in patient care by providing physicians with a powerful tool to aid the diagnosis and management of disease, particularly in precision oncology. As next-generation sequencing (NGS)-based diagnostic assays are developed, significant hurdles suc...

    journal_title:Expert review of molecular diagnostics

    pub_type: 社论

    doi:10.1586/14737159.2014.916213

    authors: Kruglyak KM,Lin E,Ong FS

    更新日期:2014-07-01 00:00:00

  • Nanobeads as a solid phase in a solute homogeneous assay format.

    abstract::The measurement of numerous samples as in drug screening or diagnostics has been improved significantly over recent years. The processing of a great number of carriers with 96, 384 or 1536 wells is not the limiting step anymore and more than 100,000 samples can be analyzed within 24 h. New challenges arise in optimizi...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章

    doi:

    authors: Schaertl S,Meyer-Almes FJ

    更新日期:2001-11-01 00:00:00

  • ST2: a novel biomarker for heart failure.

    abstract::ST2, an IL-1 receptor family member with transmembrane (ST2L) and soluble (sST2) isoforms, was originally described in the context of inflammatory and autoimmune diseases. However, after the identification of IL-33 as the functional ligand for ST2, and conceptualization of the role of ST2/IL-33 signaling in cardiac re...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/erm.10.25

    authors: Bhardwaj A,Januzzi JL Jr

    更新日期:2010-05-01 00:00:00

  • Emergent FDA biodefense issues for microarray technology: process analytical technology.

    abstract::A successful biodefense strategy relies upon any combination of four approaches. A nation can protect its troops and citizenry first by advanced mass vaccination, second, by responsive ring vaccination, and third, by post-exposure therapeutic treatment (including vaccine therapies). Finally, protection can be achieved...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章

    doi:10.1586/14737159.4.6.779

    authors: Weinberg S

    更新日期:2004-11-01 00:00:00

  • Oligonucleotide microarrays in constitutional genetic diagnosis.

    abstract::Oligonucleotide microarrays such as comparative genomic hybridization arrays and SNP microarrays enable the identification of genomic imbalances - also termed copy-number variants - with increasing resolution. This article will focus on the most significant applications of high-throughput oligonucleotide microarrays, ...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/erm.11.32

    authors: Keren B,Le Caignec C

    更新日期:2011-06-01 00:00:00

  • The introduction of syphilis point of care tests in resource limited settings.

    abstract:INTRODUCTION:Syphilis remains an important and preventable cause of stillbirth and neonatal mortality. About 1 million women with active syphilis become pregnant each year. Without treatment, 25% of them will deliver a stillborn baby and 33% a low birth weight baby with an increased chance of dying in the first month o...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1080/14737159.2017.1303379

    authors: Marks M,Mabey DC

    更新日期:2017-04-01 00:00:00

  • Thin-film technology for direct visual detection of nucleic acid sequences: applications in clinical research.

    abstract::Certain optical conditions permit the unaided eye to detect thickness changes on surfaces on the order of 20 A, which are of similar dimensions to monomolecular interactions between proteins or hybridization of complementary nucleic acid sequences. Such detection exploits specific interference of reflected white light...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.6.1.89

    authors: Jenison RD,Bucala R,Maul D,Ward DC

    更新日期:2006-01-01 00:00:00